Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Novel Missense Mutation c.690 G>C in the Fumarate Hydratase Gene Leading to the Diagnosis of FH Tumor Predisposition Syndrome. | J Dermatol | 2025 | 40515534 | PubTator, text mining | PubMed |
| Oncometabolite fumarate facilitates PD-L1 expression and immune evasion in clear cell renal cell carcinoma. | Cell Death Dis | 2025 | 40461489 | PubTator, text mining | PubMed |
| Fumarate hydratase in cancer research: scientific trends and findings over 22 years. | Discov Oncol | 2025 | 40442547 | PubTator, text mining | PubMed |
| Oncogenic role of fumarate hydratase in breast cancer: metabolic reprogramming and mechanistic insights. | Cancer Metab | 2025 | 40437625 | PubTator, text mining | PubMed |
| Prioritizing disease-associated missense variants with chemoproteomic-detected amino acids. | Am J Hum Genet | 2025 | 40412387 | PubTator, text mining | PubMed |
| RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer. | Front Immunol | 2025 | 40370450 | PubTator, text mining | PubMed |
| Diagnosis of Hereditary Leiomyomatosis and Renal Cell Cancer After Subcapsular Renal Hematoma. | IJU Case Rep | 2025 | 40336733 | PubTator, text mining | PubMed |
| P4HB, a novel succinated protein, is essential for fumarate-induced cancer metastasis. | Int J Biol Macromol | 2025 | 40318732 | PubTator, text mining | PubMed |
| A Comprehensive Guide to Enzyme Immobilization: All You Need to Know. | Molecules | 2025 | 40005249 | PubTator, text mining | PubMed |
| Whole exome sequencing identified mutations of forkhead box I 1 (FOXI1), keratin 6 C (KRT6C) and gap junction protein delta 2 (GJD2) in a low-grade oncocytic tumor of the kidney: a case report. | Diagn Pathol | 2025 | 39980061 | PubTator, text mining | PubMed |
| The impact of the new WHO classification of renal cell carcinoma on the diagnosis of hereditary leiomyomatosis and renal cell carcinoma. | Nephrol Dial Transplant | 2025 | 39979023 | PubTator, text mining | PubMed |
| Whole Genome Sequencing to Identify Novel Germline Fumarate Hydratase Mutation in Child With Bilateral Renal Cell Carcinoma. | Clin Genet | 2025 | 39904744 | PubTator, text mining | PubMed |
| Stimulator of interferon genes (STING) immunohistochemical expression in fumarate hydratase-deficient renal cell carcinoma: biological and potential predictive implications. | Virchows Arch | 2025 | 39899047 | PubTator, text mining | PubMed |
| Identifying Hereditary Leiomyomatosis and Renal Cell Cancer through Unobtrusive Cutaneous Nodules: A Clinical Report. | J Kidney Cancer VHL | 2025 | 39896049 | PubTator, text mining | PubMed |
| The Morphologic and Molecular Heterogeneity of Fumarate Hydratase-deficient Leiomyomas: Integrative Molecular Profiling of Uterine Smooth Muscle Tumors With Histologic Feature Correlation. | Int J Gynecol Pathol | 2025 | 39869100 | PubTator, text mining | PubMed |
Prospective Fumarate Hydratase Tumor Predisposition Syndrome Screening in Patients With Uterine Smooth Muscle Tumors: Age, Morphology, Fumarate Hydratase/S-(2-succino) Cysteine Immunohistochemistry, and Germline Testing. | Am J Surg Pathol | 2025 | 39835370 | PubTator, text mining | PubMed |
| Aberrant fumarate metabolism links interferon release in diffuse systemic sclerosis. | J Dermatol Sci | 2025 | 39827047 | PubTator, text mining | PubMed |
| Cytologic diagnosis of fumarate hydratase-deficient renal cell carcinoma: A single-institutional experience. | Cancer Cytopathol | 2025 | 39804329 | PubTator, text mining | PubMed |
| Update on Cancer Screening in Children with Syndromes of Bone Lesions, Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome, and Other Rare Syndromes. | Clin Cancer Res | 2025 | 39601780 | PubTator, text mining | PubMed |
| Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82. | Mol Cancer Ther | 2025 | 39397296 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=6